Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re 2016 stress test results

30 Nov 2016 07:03

RNS Number : 4848Q
Royal Bank of Scotland Group PLC
29 November 2016
 

The Royal Bank of Scotland Group plc

 

Statement on the publication of the 2016 Bank of England stress test results

 

30 November 2016

 

The Royal Bank of Scotland Group plc ("RBS") notes the announcement made today by the Bank of England ("BoE") regarding the results of its 2016 stress test. The test applied a hypothetical adverse scenario to the Group's balance sheet as at 31 December 2015 and compared the theoretical Common Equity Tier 1 ("CET1") ratio and Tier 1 leverage ratio positions of RBS before and after the impact of strategic management actions, including CRD IV distribution restrictions and conversion of Additional Tier 1 securities ("AT1").

 

RBS's low point CET1 ratio under the hypothetical adverse scenario would have been 5.5% which is below RBS's updated 6.6% Individual Capital Guidance ("ICG") and below the post-stress CET1 Systemic Reference Point ("SRP") of 7.1% (please refer to definitions in notes below the table). After the impact of management actions and restriction of the CRD IV distribution, the ratio would have been 5.9%; and subsequently 6.7% post the conversion of AT1 securities. This takes the result above the ICG hurdle rate of 6.6% but it remains below the SRP of 7.1%.

 

RBS's Tier 1 leverage ratio under the hypothetical adverse scenario would have been 2.7% which is below the hurdle rate of 3.0% and below the post-stress leverage ratio SRP of 3.2%. After the impact of management actions, the ratio would have been 2.9%, which remains below both the hurdle rate and the Tier 1 leverage ratio SRP.

 

The bank has taken a number of actions since 31 December 2015 to improve its capital position stress resilience, including the on-going run-down of Capital Resolution (risk-weighted assets ("RWAs") reduced by £10.4 billion (21%) to £38.6 billion in the first nine months of 2016), the continued reduction in higher risk credit portfolios, the settlement of various litigation cases and regulatory investigations and the issuance of an additional £2 billion equivalent in AT1 securities. A number of these actions impacted our CET1 ratio which was 15.0% as at Q3 2016, compared to 15.5% as at FY 2015. This is above RBS's CET1 ratio target of 13.0%.

 

RBS has agreed a revised capital plan with the PRA to improve its stress resilience in light of the various challenges and uncertainties facing both the bank and the wider economy highlighted by the concurrent stress testing process. RBS intends to execute an array of capital management actions to supplement the organic capital generation from its core franchises and further improve its stress resilience, including: further decreasing the cost base of the bank; further reductions in RWAs across the bank; further run-down and sale of other non-core loan portfolios in relation to our personal and commercial franchises; reduction in certain non-core commercial portfolios in Commercial Banking; and the proactive management of undrawn facilities in 2017. RBS expects its revised capital plan to address the shortfall identified in today's stress test results. However, additional management actions may be required until RBS's balance sheet is sufficiently resilient to stressed scenarios.

 

Commenting on the results, Ewen Stevenson, Chief Financial Officer, said:

 

"We are committed to creating a stronger, simpler and safer bank for our customers and shareholders. We have taken further important steps in 2016 to enhance our capital strength, but we recognise that we have more to do to restore the bank's stress resilience including resolving outstanding legacy issues."

 

Table: RBS projected consolidated solvency ratios in the stress scenario.

Minimum stressed ratio after 'strategic' management actions and before conversion of AT1

Actual

(end-2015)

Minimum stressed ratio (before the impact of 'strategic' management actions or AT1 conversion)

Non-dividend 'strategic' management actions only(i)

All 'strategic' management actions including CRD IV distribution restrictions

Minimum stressed ratio (after the impact of 'strategic' management actions and conversion of AT1)

Hurdle rate

Systematic reference point

Actual (2016 Q3)

Submit revised capital plan?

Common equity Tier 1 ratio(a)(b)

15.5%

5.5%

5.8%

5.9%

6.7%

6.6%(j)

7.1%

15.0%

Revised capital plan received and accepted

Tier 1 capital ratio(c)

19.1%

8.1%(f)

8.5%(f)

8.5%(f)

8.5%(f)

19.1%

Total capital ratio(d)

24.7%

12.5%(f)

12.8%(f)

12.9%(f)

12.9%(f)

24.1%

Memo: risk weighted assets (£ billion)

243

255(f)

255(f)

255(f)

255(f)

235

Memo: CET1

(£ billion)

37.6

14(f)

15(f)

15(f)

17(f)

35.2

Tier 1 leverage ratio(a)(e)

5.6%

2.7%

2.9%

2.9%

2.9%

3.0%

3.2%

5.6%

Memo: leverage exposure

(£ billion)

702(g)

591(h)

591(h)

591(h)

591(h)

703

Notes to table:

a) The low points for the common equity Tier 1 (CET1) ratio and leverage ratio shown in the table do not necessarily occur in the same year of the stress scenario and correspond to the year where the minimum stressed ratio is calculated after all 'strategic' management actions and before conversion of AT1.

b) The CET1 ratio is defined as CET1 capital expressed as a percentage of risk-weighted assets (RWAs) where CET1 capital is defined in line with the UK implementation of CRD IV as set out in the PRA Rulebook and in Supervisory Statement SS7/13, 'CRD IV and capital', December 2013, and RWAs are defined in line with the UK implementation of CRD IV as set out in the PRA Rulebook and relevant Supervisory Statements, December 2013.

c) Tier 1 capital ratio is defined as Tier 1 capital expressed as a percentage of RWAs where Tier 1 capital is defined as the sum of CET1 capital and additional Tier 1 capital in line with the UK implementation of CRD IV.

d) Total capital ratio is defined as total capital expressed as a percentage of RWAs where total capital is defined as the sum of Tier 1 capital and Tier 2 capital in line with the UK implementation of CRD IV.

e) The leverage ratio is calculated in line with the Policy Statement 'The Financial Policy Committee's powers over leverage ratio tools', July 2015.

f) Corresponds to the same year as the minimum CET1 ratio over the stress scenario.

g) Leverage exposure measure taken from the bank's annual accounts.

h) Corresponds to the same year as the minimum leverage ratio over its stress scenario.

i) This includes CRD IV distribution restrictions. Where a bank is subject to such restrictions all non business as usual cuts to distributions subject to CRD IV restrictions will appear in the next column - 'All 'strategic' management actions including CRD IV distribution restrictions'. This should not be interpreted as a judgement by the Bank that any or all of such cuts are conditional on such restrictions.

j) The hurdle rate for CET1 ratio refers to the Individual Capital Guidance.

 

Additional information:

1. As part of its Supervisory Review and Evaluation Process ("SREP") the PRA has reduced the CET1 Pillar 2A component of RBS's ICG from the previously disclosed 2.8% to 2.1% of RWAs.

2. ICG is the amount and quality of capital resources which the regulator requires a firm should hold at all times under the overall financial adequacy rules. RBS's 2016 CET1 ICG comprises 4.5% Pillar 1 requirement and 2.1% Pillar 2A.

3. Systemic reference point defined as sum of P1, P2A and a 25% per annum phase-in of the current 1% G-SIB buffer.

4. The projections of RBS's financial performance under hypothetical stress included in this announcement are based on the methodology and calculations of the BoE. This does not represent RBS's projections or base capital plan assumptions.

5. 'Adjusted' measures of financial performance are before own credit adjustments; gain or loss on redemption of own debt; strategic disposals; restructuring costs and litigation and conduct costs.

6. Detailed disclosure is available from the BoE website: http://www.bankofengland.co.uk/financialstability/Pages/fpc/stresstest.aspx 

7. For details of our 2015 results please refer to: http://otp.investis.com/clients/uk/rbs1/rns1/regulatory-story.aspx?cid=365&newsid=615667 

 

 

For further information, please contact:

 

Investor Relations

Alexander Holcroft

Head of Equity Investor Relations

+44 (0) 20 7672 1758

 

Matthew Richardson

Head of Fixed Income Investor Relations

+44 (0) 20 7678 1800

 

RBS Media Relations

+44 (0) 131 523 4205

 

Forward Looking Statements

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those related to RBS and its subsidiaries' regulatory capital position, risk-weighted assets, impairment losses and credit exposures under certain specified scenarios. In addition, forward-looking statements may include, without limitation, statements typically containing words such as "intends", "expects", "anticipates", "targets", "plans", "estimates" and words of similar import. These statements concern or may affect future matters, such as RBS's future economic results, business and capital plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, fiscal and regulatory developments, competitive conditions, technological developments, exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBS's actual results are discussed in RBS's UK Annual Report and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBS's Reports on Form 6-K and most recent Annual Report on Form 20-F. The forward-looking statements contained in this announcement speak only as of the date of this announcement and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRLKLLLQFFBFBK
Date   Source Headline
15th Apr 20169:22 amRNSHolding(s) in Company
14th Apr 20165:32 pmRNSAllotment and Issue of New Ordinary Shares
11th Apr 20169:00 amRNSImpact of recent Liability Management Exercise
7th Apr 20162:32 pmRNSBlock listing Interim Review
7th Apr 201612:44 pmRNSPricing and Final Results
7th Apr 201612:43 pmRNSAnnouncement of Final Results
6th Apr 20165:20 pmRNSANNOUNCEMENT OF PRICING INFORMATION
1st Apr 20162:00 pmRNSNotice of AGM
31st Mar 20162:11 pmRNSTotal Voting Rights
31st Mar 20167:00 amRNSRBSG priced $1.5 billion Senior Notes
30th Mar 20161:04 pmRNSCASH TENDER OFFERS FOR EURO AND STERLING NOTES
30th Mar 20161:03 pmRNSCASH TENDER OFFERS ON CERTAIN US DOLLAR SECURITIES
29th Mar 20167:00 amRNSFILING OF ANNUAL REPORT ON FORM 20-F WITH THE SEC
22nd Mar 20167:50 amRNSRBS and HMT to retire the DAS
18th Mar 20162:31 pmRNSPublication of Final Terms
15th Mar 20168:45 amRNSMorgan Stanley European Financials Conference
8th Mar 20162:14 pmRNSDirector/PDMR Shareholding
7th Mar 20162:14 pmRNSPublication of Prospectus
29th Feb 20164:51 pmRNSTotal Voting Rights
29th Feb 20162:00 pmRNSDirector/PDMR Shareholding
26th Feb 20167:01 amRNSAnnual Report and Accounts 2015
26th Feb 20167:00 amRNSFinal Results
25th Feb 20165:36 pmRNSHome Member State Confirmations
25th Feb 20164:23 pmRNSDividend Declaration
4th Feb 20163:59 pmRNSRBS February 2016 Restatement
29th Jan 20162:55 pmRNSTotal Voting Rights
27th Jan 20167:00 amRNSTrading Statement
7th Jan 201611:02 amRNSHolding(s) in Company
6th Jan 201611:43 amRNSTotal Voting Rights
31st Dec 201510:50 amRNSTotal Voting Rights
17th Dec 20155:32 pmRNSAllotment and Issue of New Ordinary Shares
17th Dec 20158:59 amRNSAppointment of a Non-Executive Director
16th Dec 20157:27 amRNSUpdate on the disposal of Williams & Glyn - Amend
16th Dec 20157:00 amRNSUpdate on the disposal of Williams & Glyn
7th Dec 20157:20 amRNSDisposal of a portfolio of Irish Real Estate Loans
1st Dec 20157:07 amRNSStatement re 2015 stress test results
30th Nov 20153:15 pmRNSTotal Voting Rights
26th Nov 20155:19 pmRNSImpact of recent Liability Management Exercise
23rd Nov 20153:32 pmRNSPublication of Prospectus
19th Nov 20155:11 pmRNSDividend Declaration
12th Nov 201512:51 pmRNSRBS Investor Seminar: CIB
12th Nov 20159:54 amRNSDirector Declaration
10th Nov 20152:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20151:40 pmRNSVisa Europe Shareholding
30th Oct 20153:35 pmRNSTotal Voting Rights
30th Oct 201512:05 pmRNSDisposal
30th Oct 20157:05 amRNSSale of Remainder of Citizens Financial Group Inc.
30th Oct 20157:00 amRNSInterim Management Statement
15th Oct 20154:00 pmRNSHolding(s) in Company
14th Oct 20158:16 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.